A Jewish student has filed a lawsuit against Rutgers University, alleging the institution ignored antisemitism on campus. Meanwhile, Moderna's stock ($MRNA) surged by over 13% at the start of 2024, reaching a new high since September 18. Oppenheimer upgraded the stock to outperform with a price target of $142, citing potential product launches in the next 18 months. The closure of the Lukeville Port of Entry has led to criticism, with claims that it has not curbed the surge of migrants and has disrupted trade, commerce, tourism, and travel across the border. Maryland is facing backlash for causing significant traffic delays on a major interstate due to a singular lane closure sign.
Maryland, you really do suck. I can’t imagine a worse state than one that slows down commerce and commuting traffic on a major interstate by placing a singular lane closure sign that causes a 19 minute delay backup just to have the sign say “slow down” and that’s it. The. Worst.
The closure of the Lukeville Port of Entry accomplished nothing to curb the surge of migrants we’re continuing to see. Instead, it shut down trade, commerce, tourism and travel across the border during one of the busiest times of the year. This action is just another example of… https://t.co/QBKi1pr0Nv
Send 🍕 https://t.co/uFf6KFFwzS
$MRNA opened the year 2024 w/ a big 13%+ jump, a new high since 9/18. Oppenheimer upgraded it to outperform w/ with a price target of $142, highlighting potential product launches in the next 18 months that could boost sales in 2025. Hedge funds that are bullish on the stock… https://t.co/vgbl8mO4Bz
Everyone needs shoes. Everyone needs housing. One of these markets is broken. https://t.co/OLGreonNNg
Jewish student claims Rutgers University ignored antisemitism on campus in new lawsuit https://t.co/NZV3r0YUBW https://t.co/dX9NjV3nhC